AKT1 and colorectal carcinoma: This is also starting to be obvious from in vitro studies where various phytochemicals influence the key signaling pathways involved in CRC, such as MAPK, mTOR, PI3K/AKT, and JAK/STAT, with the potential for synergistic effects that could enhance anticancer outcomes [7,9].